Full-Time
Posted on 4/15/2025
Develops technologies for peripheral nerve repair
$55.1k - $68.8k/yr
Entry, Junior
Mansfield, TX, USA
Axogen specializes in developing and commercializing technologies aimed at repairing and regenerating peripheral nerves. Their products are designed to assist surgeons and healthcare providers in restoring nerve function for patients who have experienced physical damage or discontinuity in their peripheral nerves due to traumatic injuries or surgical procedures. Axogen's solutions help address issues such as loss of muscle function, sensory feeling, and pain caused by nerve damage. What sets Axogen apart from its competitors is its dedicated focus on peripheral nerve repair, offering a comprehensive range of clinically proven and cost-effective products. The company's goal is to improve the quality of life for patients by enabling them to regain essential functions like touch, movement, and sensation.
Company Size
201-500
Company Stage
IPO
Headquarters
Alachua, Florida
Founded
2002
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
401(k) Company Match
Paid Vacation
Paid Holidays
Employee Stock Purchase Plan
Tuition Reimbursement
Paid Parental Leave
Paid Caregiver Leave
Basic Life Insurance
Supplemental Life Insurance
Disability Insurance
Axogen, Inc. (AXGN), a developer of innovative surgical solutions for peripheral nerve injuries, announced the appointment of Lindsey Hartley as Chief Financial Officer, effective May 12, 2025.
ALACHUA, Fla. and TAMPA, Fla., March 24, 2025 (GLOBE NEWSWIRE) - Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced the appointment of Rick Ditto as Vice President, Global Health Economics, Reimbursement & Policy.
ALACHUA, Fla. and TAMPA, Fla., Jan. 10, 2025 (GLOBE NEWSWIRE) - Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced the appointment of Craig Swandal as Vice President of Operations.
Dr. Peterson, an experienced clinical researcher with a background in both academic and industry roles, joins from Axogen, where he specialized in therapies for peripheral nerve repair.
Axogen names ex-abbott exec Michael Dale as CEO.